Gemtuzumab and malignant neoplasm progression Patient Reports February 13, 2012

Gemtuzumab Side Effects Report #5023836-5
Gemtuzumab side effect was reported by a Health Professional from FRANCE on May 30, 2006. Male patient, 38 years of age, was diagnosed with myeloid leukaemia and was treated with Gemtuzumab. After drug was administered, patient experienced the following side effects: blast cells present, disease progression, haemoglobin decreased, interstitial lung disease, leukocytosis, leukostasis, malignant neoplasm progression, myeloid leukaemia. Gemtuzumab dosage: 5 MG 1X PER 1 DAY INTRAVENOUS; SEE IMAGE. During the same period patient was treated with GEMTUZUMAB OZOGAMICIN, GEMTUZUMAB OZOGAMICIN, HYDREA, FLUCONAZOLE, FANSIDAR, ZOVIRAX, BACTRIM. Patient was hospitalized. Patient died.

Gemtuzumab Side Effects Report #5096653-8
Gemtuzumab side effect was reported by a Consumer or non-health professional from FRANCE on Aug 21, 2006. Male patient was diagnosed with juvenile chronic myelomonocytic leukaemia and was treated with Gemtuzumab. After drug was administered, patient experienced the following side effects: anaphylactic shock, haematotoxicity, hyperbilirubinaemia, juvenile chronic myelomonocytic leukaemia, malignant neoplasm progression, transaminases increased. Gemtuzumab dosage: A SINGLE DOSE, 9 MG/M^2. Patient recovered.

Gemtuzumab Side Effects Report #5096613-7
Gemtuzumab side effect was reported by a Consumer or non-health professional from FRANCE on Aug 21, 2006. Male patient, child 8 years of age, was diagnosed with acute myeloid leukaemia and was treated with Gemtuzumab. After drug was administered, patient experienced the following side effects: acute myeloid leukaemia, cholecystitis acute, cystitis haemorrhagic, febrile neutropenia, malignant neoplasm progression. Gemtuzumab dosage: 9 MG/M^2 1X PER 1 DAY; DAYS 1 AND 14. Patient recovered.

Gemtuzumab Side Effects Report #4869678-2
Gemtuzumab side effect was reported by a Consumer or non-health professional from FRANCE on Dec 20, 2005. Female patient, 71 years of age, was diagnosed with acute myeloid leukaemia and was treated with Gemtuzumab. After drug was administered, patient experienced the following side effects: acute myeloid leukaemia, malignant neoplasm progression. Gemtuzumab dosage: unknown. Patient died.


Gemtuzumab Side Effects Report #4875724-2
Gemtuzumab side effect was reported by a Consumer or non-health professional from FRANCE on Jan 02, 2006. Female patient, 71 years of age, was diagnosed with acute myeloid leukaemia and was treated with Gemtuzumab. After drug was administered, patient experienced the following side effects: acute myeloid leukaemia, malignant neoplasm progression. Gemtuzumab dosage: unknown. Patient died.

Gemtuzumab Side Effects Report #4869650-2
Gemtuzumab side effect was reported by a Consumer or non-health professional from FRANCE on Dec 20, 2005. Male patient, 70 years of age, was diagnosed with acute myeloid leukaemia and was treated with Gemtuzumab. After drug was administered, patient experienced the following side effects: acute myeloid leukaemia, malignant neoplasm progression. Gemtuzumab dosage: unknown. Patient died.

Gemtuzumab Side Effects Report #4869651-4
Gemtuzumab side effect was reported by a Consumer or non-health professional from FRANCE on Dec 20, 2005. Male patient, 70 years of age, was diagnosed with acute myeloid leukaemia and was treated with Gemtuzumab. After drug was administered, patient experienced the following side effects: acute myeloid leukaemia, malignant neoplasm progression. Gemtuzumab dosage: unknown. Patient died.

Gemtuzumab Side Effects Report #4869677-0
Gemtuzumab side effect was reported by a Consumer or non-health professional from FRANCE on Dec 20, 2005. Male patient, 70 years of age, was diagnosed with acute myeloid leukaemia and was treated with Gemtuzumab. After drug was administered, patient experienced the following side effects: acute myeloid leukaemia, bronchopulmonary aspergillosis, malignant neoplasm progression. Gemtuzumab dosage: unknown. Patient died.

Gemtuzumab Side Effects Report #4875726-6
Gemtuzumab side effect was reported by a Consumer or non-health professional from FRANCE on Jan 02, 2006. Male patient, 70 years of age, was diagnosed with acute myeloid leukaemia and was treated with Gemtuzumab. After drug was administered, patient experienced the following side effects: acute myeloid leukaemia, bronchopulmonary aspergillosis, malignant neoplasm progression. Gemtuzumab dosage: unknown. Patient died.


Gemtuzumab Side Effects Report #4875728-X
Gemtuzumab side effect was reported by a Consumer or non-health professional from FRANCE on Jan 02, 2006. Male patient, 70 years of age, was diagnosed with acute myeloid leukaemia and was treated with Gemtuzumab. After drug was administered, patient experienced the following side effects: acute myeloid leukaemia, malignant neoplasm progression. Gemtuzumab dosage: unknown. Patient died.

Gemtuzumab Side Effects Report #4875729-1
Gemtuzumab side effect was reported by a Consumer or non-health professional from FRANCE on Jan 02, 2006. Male patient, 70 years of age, was diagnosed with acute myeloid leukaemia and was treated with Gemtuzumab. After drug was administered, patient experienced the following side effects: acute myeloid leukaemia, malignant neoplasm progression. Gemtuzumab dosage: unknown. Patient died.

Gemtuzumab Side Effects Report #4867030-7
Gemtuzumab side effect was reported by a Health Professional from GERMANY on Mar 10, 2002. Male patient, 58 years of age, was diagnosed with acute myeloid leukaemia and was treated with Gemtuzumab. After drug was administered, patient experienced the following side effects: acute myeloid leukaemia, aplasia, arrhythmia , epistaxis, malignant neoplasm progression, melaena, thrombocytopenia. Gemtuzumab dosage: 9 MG/M^2 1X PER 1 DOS INTRAVENOUS. During the same period patient was treated with GEMTUZUMAB OZOGAMICIN. Patient died.